Halozyme (HALO) EBITDA margin US GAAP (year values)

2020 2021 2022 2022 2023   LTM ?
EBITDA margin, % ? 57.2% 58.4% 47.8% 47.8% 54.5%   60.2%
Changes by years, y/y, % +86pp +1pp -11pp 0pp +7pp    

Halozyme. EBITDA margin, %

Halozyme. EBITDA margin, changes, pp

Halozyme (HALO) EBITDA margin US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA margin, % ? 59.9% 55.2% 59.1% 59.5% 65.5%   60.2%
Changes by years, y/y, % +6pp +12pp +15pp +7pp +6pp    
Changes by quarters, q/q, % +8pp -5pp +4pp +0pp +6pp    

Halozyme. EBITDA margin, %

Halozyme. EBITDA margin, changes, pp

Halozyme. EBITDA margin, changes, pp